High-dose therapy and autologous stem cell transplantation during remission in poor-risk age-adjusted international prognostic index high and high-intermediate risk group patients with intermediate grade and high-grade non-Hodgkin's lymphoma including mantle cell lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmustine; Cyclophosphamide; Etoposide
- Indications Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 11 Aug 2015 Biomarkers information updated
- 20 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.